Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children

Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics

(2021) Steven T. Proulx   CELLULAR AND MOLECULAR LIFE SCIENCES

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

(2021) Tamara Dangouloff et al.   NEUROMUSCULAR DISORDERS

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years

(2021) Katharina Vill et al.   Orphanet Journal of Rare Diseases

Muscle-specific SMN reduction reveals motor neuron–independent disease in spinal muscular atrophy models

(2020) Jeong-Ki Kim et al.   JOURNAL OF CLINICAL INVESTIGATION

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis

(2020) Marie-Christine Reinert et al.   Neurology-Neuroimmunology & Neuroinflammation

Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?

(2020) Elena Abati et al.   NEUROBIOLOGY OF DISEASE

A multi-center study of neurofilament assay reliability and inter-laboratory variability

(2020) Elizabeth Gray et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

NFL is a marker of treatment response in children with SMA treated with nusinersen

(2019) Bob Olsson et al.   JOURNAL OF NEUROLOGY

Neurofilament as a potential biomarker for spinal muscular atrophy

(2019) Basil T. Darras et al.   Annals of Clinical and Translational Neurology

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen

(2019) Claudia D. Wurster et al.   JOURNAL OF NEUROLOGY

Advances in therapy for spinal muscular atrophy: promises and challenges

(2018) Ewout J. N. Groen et al.   Nature Reviews Neurology

Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care

(2018) Eugenio Mercuri et al.   NEUROMUSCULAR DISORDERS

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

(2018) Eugenio Mercuri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein

(2018) Noriko Otsuki et al.   PLoS One

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease

(2018) Vamshi K. Rao et al.   Journal of Managed Care & Specialty Pharmacy

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

(2017) Aylin Yilmaz et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

(2017) Richard S. Finkel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Astrocytes influence the severity of spinal muscular atrophy

(2015) Hansjörg Rindt et al.   HUMAN MOLECULAR GENETICS

Observational study of spinal muscular atrophy type I and implications for clinical trials

(2014) R. S. Finkel et al.   NEUROLOGY

A comparative study of CSF neurofilament light and heavy chain protein in MS

(2013) Jens Kuhle et al.   Multiple Sclerosis Journal

Validation of the Childrenʼs Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)

(2011) Allan M. Glanzman et al.   Pediatric Physical Therapy

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Spinal muscular atrophy

(2008) Mitchell R Lunn et al.   LANCET